Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Hazem, Assi"'
Autor:
Alain Abi Ghanem, Tamara El Annan, Nour El Ghawi, Nadine Omran, Mustafa Natout, Hazem Assi, Ali Shamseddine, Nina Saliba, Mohamad Haidar
Publikováno v:
Diagnostics, Vol 14, Iss 15, p 1622 (2024)
Fibroblast Activation Protein Inhibitor (FAPI) positron emission tomography (PET) imaging has emerged as a useful method for identifying pancreatic disorders, notably pancreatitis. Unlike Fluorine-18 fluorodeoxyglucose (FDG), FAPI uptake is directly
Externí odkaz:
https://doaj.org/article/0ec7a1aa71894de19d021ef9ef2a7816
Autor:
Mariam Zahwe, Aya El Sammak, Karim Ataya, Christelle Jabbour, Ayman Bsat, Bassel Hafez, Christine Atallah, Mira Kheil, Mohamad Ali Maktabi, Bashar Hassan, Vahe Panossian, Hazem Assi, Jaber Abbas, Eman Sbaity
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Background The feasibility of sentinel lymph node biopsy (SLNB) after neoadjuvant chemotherapy (NACT) in initially node‐positive patients is still controversial. We aim to evaluate the oncologic outcomes of SLNB after NACT and further comp
Externí odkaz:
https://doaj.org/article/094e507ab1284fd98fa3c4bd70426e12
Autor:
Nagi S. El Saghir, Lana E. Khalil, Joud El Dick, Rula W. Atwani, Nadine Safi, Maya Charafeddine, Ahmad Al-Masri, Bassem N. El Saghir, Maha Chaccour, Arafat Tfayli, Hazem Assi, Jaber Abbas, Zeina Ayoub, Eman Sbaity, Hiba A. Moukadem
Publikováno v:
JCO Global Oncology, Vol , Iss 9 (2023)
PURPOSEAround 50% of patients with breast cancer in low- or middle-income countries are younger than 50 years, a poor prognostic variable. We report the outcome of patients with breast cancer 40 years and younger.METHODSWe reviewed 386 patients with
Externí odkaz:
https://doaj.org/article/c8cccfd6a4d745d48bd6ddb55d5dc5c6
Autor:
Arafat Tfayli, Majd Al Assaad, Ghina Fakhri, Reem Akel, Hanine Atwi, Hady Ghanem, Fadi El Karak, Fadi Farhat, Kamal Al Rabi, Pierre Sfeir, Pierre Youssef, Ziad Mansour, Hazem Assi, Mohamad Haidar, Alain Abi Ghanem, Ibrahim Khalifeh, Fouad Boulos, Ramy Mahfouz, Bassem Youssef, Youssef Zeidan, Rachelle Bejjany, Fadlo Khuri
Publikováno v:
Cancer Medicine, Vol 9, Iss 22, Pp 8406-8411 (2020)
Abstract Multiple randomized studies have shown that combination of chemotherapy and immune checkpoint inhibitors (ICIs) leads to better response rates and survival as compared to chemotherapy alone in the advanced stage of NSCLC. Data suggesting a b
Externí odkaz:
https://doaj.org/article/d6eb58e736a745a1befdf7c504496b67
Autor:
Lara Nassar, Mutaz Kassas, Alain S. Abi-Ghanem, Malak El-Jebai, Safaa Al-Zakleet, Amro S. Baassiri, Rami Abou Naccoul, Andrew Barakat, Arafat Tfayli, Hazem Assi, Ghina Berjawi, Enrique Estrada-Lobato, Francesco Giammarile, Sobhan Vinjamuri, Mohamad Haidar
Publikováno v:
Diagnostics, Vol 13, Iss 3, p 367 (2023)
Supine [18F]Fluorodeoxyglucose (FDG) positron emission technology/computed tomography (PET/CT) is a commonly used modality for the initial staging of breast cancer, and several previous studies have shown superior sensitivity and specificity of prone
Externí odkaz:
https://doaj.org/article/69e16f2ef72f4ab8822d66d5409a69b2
Publikováno v:
Journal of International Medical Research, Vol 48 (2020)
Objective This study was performed to determine the subtypes of phyllodes tumor (PT) in patients at a single tertiary healthcare center in Lebanon and to describe their characteristics along with a review of the literature. Methods This single-instit
Externí odkaz:
https://doaj.org/article/8e26b66711bb4f6da412cb32569dc682
Autor:
Rola El Sayed, Lara El Jamal, Sarah El Iskandarani, Jeries Kort, Mahmoud Abdel Salam, Hazem Assi
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Background: Advanced hormone-receptor positive HER2 negative breast cancer is a common and a very heterogeneous disease. Hormone therapy is the main first line treatment of choice, given alone or in combination with other agents that have shown to im
Externí odkaz:
https://doaj.org/article/aa490e3ba236487da90427a4d26eb2f9
Autor:
Shadi Bsat, Charbel Moussalem, Sarah kawtharani, Mohamad Nabih El Houshiemy, Adham Halaoui, Tatiana Saba, Marwan Najjar, Hazem Assi, Jana Baajour, Ibrahim El-Houcheimi, George Abi Saad, Houssein Darwish
Publikováno v:
World Neurosurgery. 162:e659-e663
In this paper, we shed the light on Beirut's blast that took place in the coronavirus disease 2019 (COVID-19) era. An explosion that ripped the heart of Beirut, it produced a destructive shock wave that left thousands of casualties and people homeles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19eee5fa1c8369aa6ffac0b3d12dd210
https://doi.org/10.1016/j.wneu.2022.03.112
https://doi.org/10.1016/j.wneu.2022.03.112
Autor:
Steven J. O'Day, Jonathan Siegel, David Berman, Anthony Maraveyas, Hazem Assi, Ruggero Ridolfi, Ilan Ron, Asim Amin, David Minor, Omid Hamid, John A. Thompson, Jeffrey Weber
Supplementary Data from A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Comparing the Tolerability and Efficacy of Ipilimumab Administered with or without Prophylactic Budesonide in Patients with Unresectable Stage III or IV Melanoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1eb966dc51bbba4300f3da2c49abf3e2
https://doi.org/10.1158/1078-0432.22440760.v1
https://doi.org/10.1158/1078-0432.22440760.v1
Autor:
Steven J. O'Day, Jonathan Siegel, David Berman, Anthony Maraveyas, Hazem Assi, Ruggero Ridolfi, Ilan Ron, Asim Amin, David Minor, Omid Hamid, John A. Thompson, Jeffrey Weber
Purpose: Diarrhea (with or without colitis) is an immune-related adverse event (irAE) associated with ipilimumab. A randomized, double-blind, placebo-controlled, multicenter, multinational phase II trial was conducted to determine whether prophylacti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f84bdb2347ee6e3095b875e3aca0676
https://doi.org/10.1158/1078-0432.c.6518050.v1
https://doi.org/10.1158/1078-0432.c.6518050.v1